Vascular pathology in Alzheimer's disease
- PMID: 20608291
- DOI: 10.1111/j.1479-8301.2009.00294.x
Vascular pathology in Alzheimer's disease
Abstract
Histopathologically, numerous senile plaques and neurofibrillary tangles were remarkably observed in the brain with Alzheimer's disease. At the same time, so much simple atrophy of nerve cells was evident under light microscopy.Electron microscopical observations of serial sections revealed that small blood vessels, including capillaries, had a deep relationship to the amyloid fibrils which formed the senile plaques and they had fallen into degenerative states. The vascular feet of the astroglial cells surrounding small blood vessels showed degenerative features, and many nerve cells in this area either showed various degrees of degeneration or apparently were destroyed. The atrophy of the brain with Alzheimer's disease is considered to be caused by the amyloid angiopathy of small blood vessels and the degeneration of capillaries and vascular feet. These findings strongly suggest that the major causal mechanism of Alzheimer's disease is an alteration of the blood-brain barrier. Morphology is an expression of both the structure and the function of organs in the living body. Based on this viewpoint, this review article emphasizes that the morphological changes to small blood vessels in the brain with Alzheimer's disease convey crucial information and clues for solving the underlying mechanism that causes the disease.
Similar articles
-
Vascular pathology in Alzheimer's disease.Ann N Y Acad Sci. 2002 Nov;977:303-5. doi: 10.1111/j.1749-6632.2002.tb04830.x. Ann N Y Acad Sci. 2002. PMID: 12480765
-
Electron microscopy of amyloid fibrils and microvessels.Ann N Y Acad Sci. 1997 Sep 26;826:25-34. doi: 10.1111/j.1749-6632.1997.tb48458.x. Ann N Y Acad Sci. 1997. PMID: 9329678
-
Amyloid angiopathy of Alzheimer's disease: amino acid composition and partial sequence of a 4,200-dalton peptide isolated from cortical microvessels.J Neurochem. 1987 Nov;49(5):1394-401. doi: 10.1111/j.1471-4159.1987.tb01005.x. J Neurochem. 1987. PMID: 3312495
-
The blood-brain barrier and cerebrovascular pathology in Alzheimer's disease.Ann N Y Acad Sci. 1999;893:113-25. doi: 10.1111/j.1749-6632.1999.tb07821.x. Ann N Y Acad Sci. 1999. PMID: 10672233 Review.
-
An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease.Neurobiol Aging. 1986 Nov-Dec;7(6):489-502. doi: 10.1016/0197-4580(86)90086-2. Neurobiol Aging. 1986. PMID: 2882432 Review.
Cited by
-
APOE genotype dependent molecular abnormalities in the cerebrovasculature of Alzheimer's disease and age-matched non-demented brains.Mol Brain. 2021 Jul 8;14(1):110. doi: 10.1186/s13041-021-00803-9. Mol Brain. 2021. PMID: 34238312 Free PMC article.
-
Therapies for Prevention and Treatment of Alzheimer's Disease.Biomed Res Int. 2016;2016:2589276. doi: 10.1155/2016/2589276. Epub 2016 Jul 28. Biomed Res Int. 2016. PMID: 27547756 Free PMC article. Review.
-
Nutraceutical agents with anti-inflammatory properties prevent dietary saturated-fat induced disturbances in blood-brain barrier function in wild-type mice.J Neuroinflammation. 2013 Jun 19;10:73. doi: 10.1186/1742-2094-10-73. J Neuroinflammation. 2013. PMID: 23782872 Free PMC article.
-
A Historical Review of Brain Drug Delivery.Pharmaceutics. 2022 Jun 16;14(6):1283. doi: 10.3390/pharmaceutics14061283. Pharmaceutics. 2022. PMID: 35745855 Free PMC article. Review.
-
Peripheral Inflammation, Apolipoprotein E4, and Amyloid-β Interact to Induce Cognitive and Cerebrovascular Dysfunction.ASN Neuro. 2017 Jul-Aug;9(4):1759091417719201. doi: 10.1177/1759091417719201. ASN Neuro. 2017. PMID: 28707482 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical